LHC Group

LHC Group Equity

Delisted·Mar 3, 2023

The The Equity of LHC Group (LHCG) as of Oct 21, 2026 is 1.60 B USD. In the previous year, The Equity was 1.57 B USD — a change of 1.86% (higher).

Equity

1.60 BUSD

YoY

1.86%

Last updated:

In 2022, LHC Group's equity was 1.60 B USD, a 1.86% increase from the 1.57 B USD equity in the previous year.

The LHC Group Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2015
354.58 M USD
Jan 1, 2016
395.13 M USD
Jan 1, 2017
448.87 M USD
Jan 1, 2018
1.32 B USD
Jan 1, 2019
1.41 B USD
Jan 1, 2020
1.53 B USD
Jan 1, 2021
1.57 B USD
Jan 1, 2022
1.60 B USD
The LHC Group Equity history
YEAREquityYoY
1.60 BUSD+1.86%
1.57 BUSD+2.45%
1.53 BUSD+8.17%
1.41 BUSD+7.32%
1.32 BUSD+193.39%
448.87 MUSD+13.60%
395.13 MUSD+11.43%
354.58 MUSD+11.28%
318.64 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

LHC Group Stock analysis

What does LHC Group do? The LHC Group Inc. is an American company operating in the healthcare sector. The company is based in Lafayette, Louisiana and was founded in 1994 by Keith Myers and Mark Baiada. Since then, the company has become one of the largest and most profitable providers of home care and hospital services in the USA. LHC Group's business model is based on providing high-quality services and building strong relationships with customers. The company offers a wide range of services, including home care, rehabilitation, infusion therapy, palliative care, hospice care, oncology care, and medical logistics. The various divisions of LHC Group are tailored to different individuals and needs. The home care division provides support to patients who are limited by illness or injury in their everyday tasks such as eating, getting dressed, and bathing. The company's rehabilitation division gives patients access to experienced therapists who help improve their mobility and well-being. The infusion and oncology division provides patients with specialized treatments such as chemotherapy and antibiotic infusions. LHC Group's palliative and hospice division offers palliative care and pain management to patients suffering from serious illnesses. The company's medical logistics division provides hospitals and other healthcare facilities with the necessary medical supplies and support. LHC Group works closely with hospitals and other healthcare facilities to ensure that patients receive the care and support they need after being discharged. The company takes pride in building and maintaining close relationships with customers and other providers. Over the years, LHC Group has made several successful acquisitions and operates both in the USA and internationally. The company has expanded its presence in the European market by acquiring a majority stake in the Serbian company Gastromed. In 2020, the company also formed a strategic partnership with the University of Southern California (USC) to enhance the provision of home healthcare and palliative care in the Los Angeles region. Overall, LHC Group is a leading company in the healthcare industry, providing high-quality services and products. The company has expanded its business in diverse ways and strives to continue offering innovative solutions to meet the needs of patients and customers. LHC Group is one of the most popular companies on Eulerpool.

Equity Details

Analyzing LHC Group's Equity

LHC Group's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding LHC Group's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating LHC Group's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

LHC Group's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in LHC Group’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about LHC Group stock

The Equity of LHC Group is 1.60 B USD in 2022.

The Equity of LHC Group changed from 1.57 B USD to 1.60 B USD, representing a 1.86% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity LHC Group since 2006 – with annual values, charts, and detailed analysis.

The Equity's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's LHC Group historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — LHC Group

All Key Metrics — LHC Group